|
|
| Thérapies > Etude de marché sectorielle |
|
|
|
|
€ 160,00 |
Editeur
: |
Datamonitor |
Langue
: |
Anglais |
Date de publication : |
Janvier 2005 |
Taille du document : |
31 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
|
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
Nutraceuticals - Targeting Consumers Aged 14 –34
146 pages | Septembre 2000 |
The 14-34 age group represents approximately 30% of the total population across the 8 countries covered in the report, and as such are a key target audience.
This group is particularly critic |
955,00 €
|
| |
| |
US Antidepressants 2004
12 pages | Décembre 2004 |
Snapdata's US Antidepressants 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the US antidepressant market, and |
240,00 €
|
| |
| |
05-070: The Neuroscience Perspective: Opportunities for Market Entry & Expansion
138 pages | Octobre 2005 |
This report provides suppliers with critical information regarding neuroscientists’ preferred techniques and instrumentation in four strategic areas: nucleic acids, proteins, cells and imaging |
2 400,00 €
|
| |
| |
MarketWatch: Cancer
29 pages | Avril 2005 |
Datamonitor's Cancer MarketWatch is a one-stop news shop for time-pressed executives.
It provides monthly insight into the key events in the cancer therapeutic area.
MarketWatch features all the |
160,00 €
|
| |
| |
Commercial Insight: Cytotoxics - Generic Adversity Facing Major Cytotoxics
126 pages | Juillet 2005 |
IntroductionThere is a plethora of cytotoxics on the market but only a few dominate in terms of sales.
Yet, patents for major drugs are expected to expire in the short to mid term, and sales will d |
12 160,00 €
|
| |
| |
Cancer Vaccines: Measuring Market Potential
232 pages | Octobre 2004 |
This report provides an overview of the emerging market for cancer vaccines and measures their potential impact on a number of cancer markets.
Vaccine product candidates are discussed within the co |
1 200,00 €
|
| |
| |
MarketWatch: CNS
29 pages | Octobre 2005 |
Datamonitor's CNS MarketWatch is a one-stop news shop for timepressed executives.
It provides monthly insight into the key events in the CNS industry.
The report contains the latest news, analys |
170,00 €
|
| |
| |
MarketWatch: CNS
28 pages | Juin 2005 |
Datamonitor's CNS MarketWatch is a one-stop news shop for timepressed executives.
It provides monthly insight into the key events in the CNS industry.
The report contains the latest news, analys |
160,00 €
|
| |
| |
The Cancer Outlook 2000
128 pages | Septembre 2000 |
Driven by the cytotoxic, adjunct and innovative drug classes, the cancer market grew by 16% in 1999 to a global value of almost $19bn, and is now poised on the verge of a period of significant exp |
955,00 €
|
| |
| |
Pipeline Insight: ADHD - Shire Driving Diversity in ADHD
205 pages | Juin 2005 |
IntroductionThe current ADHD market has long been saturated with traditional methylphenidate and amphetamine based drugs, with the only innovations being the development of extended release versions.< |
9 120,00 €
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
|
|
Datamonitor's Cancer MarketWatch is a one-stop news shop for time-pressed executives. It provides monthly insight into the key events in the cancer therapeutic area. MarketWatch features all the major current business issues and events, including R&D news, licensing deals, alliances and joint ventures, and regulatory decisions.
|
|
In this month’s MarketWatch…
This month's highlights
Page 2 - Key Announcements
Page 2 - Cancer News Round-up
Lung Cancer News
Page 4 - News Headlines
Page 4 - R&D Update
Page 5 - Regulatory Update
Lymphoma News
Page 7 - News Headlines
Page 7 - R&D Update
Page 8 - Licensing & Collaborations Update
Leukemia News
Page 10 - Opinion
Page 11 - News Headlines
Page 11 - R&D Update
Page 13 - Regulatory Update
Other Cancers News
Page 14 - Opinion
Page 16 - News Headlines
Page 16 - Breast Cancer Update
Page 18 - Prostate Cancer Update
Page 20 - Colorectal Cancer Update
Feature Analysis
Page 21 - Sorafenib offers hope in the battle for liver cancer survival…
Company Spotlight
Page 23 – Roche Group
Further Reading
Page 29
Index
Page 30 - Pharma companies
Page 30 - Biotech companies
Page 31 - Key drugs
|
|
|
PPLSEN
|
|
|
|
|
